Leukocyte adhesion deficiency type I

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
B Haematology (ATC B) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase I/II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase I/II

1 trial
  • Rocket Pharmaceuticals Inc. Commercial
    AUTOLOGOUS CD34+ HAEMATOPOIETIC STEM CELLS GENETICALLY MODIFIED WITH LENTIVIRAL VECTOR ENCODING THE CD18 GENE
    2022-501086-41-00 1 country 2023 n=1 Orphan
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Rocket Pharmaceuticals Inc. Commercial 1 Phase I/II 0
New trials by year
2023
1
← All indication landscapes